At this time, the firm appears to be overvalued. ADENTRA shows a prevailing Real Value of USD37.03 per share. The current price of the firm is USD38.62. Our model approximates the value of ADENTRA from evaluating the firm fundamentals such as Profit Margin of 0.02 %, return on equity of 0.0699, and Current Valuation of 1.8 B as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ADENTRA's valuation include:
Price Book
1.0479
Enterprise Value
1.8 B
Enterprise Value Ebitda
7.07
Price Sales
0.4146
Forward PE
10.0604
Overvalued
Today
38.62
Please note that ADENTRA's price fluctuation is very steady at this time. Calculation of the real value of ADENTRA is based on 3 months time horizon. Increasing ADENTRA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ADENTRA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ADENTRA Stock. However, ADENTRA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 38.62
Real 37.03
Hype 38.67
The intrinsic value of ADENTRA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ADENTRA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ADENTRA helps investors to forecast how ADENTRA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ADENTRA more accurately as focusing exclusively on ADENTRA's fundamentals will not take into account other important factors:
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ADENTRA's intrinsic value based on its ongoing forecasts of ADENTRA's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ADENTRA's closest peers.
ADENTRA Cash
33.94 Million
ADENTRA Total Value Analysis
ADENTRA is presently estimated to have takeover price of 1.8 B with market capitalization of 938.05 M, debt of 623.07 M, and cash on hands of 7.76 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ADENTRA fundamentals before making investing decisions based on enterprise value of the company
About 23.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. ADENTRA last dividend was issued on the 19th of January 2026. The entity had 3:2 split on the 16th of August 1995. Based on the key measurements obtained from ADENTRA's financial statements, ADENTRA may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ADENTRA has an asset utilization ratio of 156.28 percent. This suggests that the Company is making USD1.56 for each dollar of assets. An increasing asset utilization means that ADENTRA is more efficient with each dollar of assets it utilizes for everyday operations.
Housing Crash
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
ADENTRA Profitability Analysis
Based on the key profitability measurements obtained from ADENTRA's financial statements, ADENTRA may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess ADENTRA's ability to earn profits and add value for shareholders.
Net Income
First Reported
2005-03-31
Previous Quarter
22.1 M
Current Value
10.1 M
Quarterly Volatility
10.1 M
Housing Crash
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
As of the 8th of February 2026, Gross Profit is likely to grow to about 572.4 M, while Pretax Profit Margin is likely to drop 0.02.
For ADENTRA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ADENTRA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ADENTRA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ADENTRA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ADENTRA over time as well as its relative position and ranking within its peers.
ADENTRA Earnings per Share Projection vs Actual
By analyzing ADENTRA's earnings estimates, investors can diagnose different trends across ADENTRA's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for ADENTRA is based on EPS before non-recurring items and includes expenses related to employee stock options.
Housing Crash
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
ADENTRA is projected to generate 0.4 in earnings per share on the 31st of December 2025. ADENTRA earnings estimates show analyst consensus about projected ADENTRA EPS (Earning Per Share). It derives the highest and the lowest estimates based on ADENTRA's historical volatility. Many public companies, such as ADENTRA, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.
ADENTRA Ownership Allocation
ADENTRA retains a total of 24.22 Million outstanding shares. ADENTRA shows 11.19 percent of its outstanding shares held by insiders and 22.81 percent owned by other corporate entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
ADENTRA Profitability Analysis
The company reported the revenue of 2.18 B. Net Income was 46.48 M with profit before overhead, payroll, taxes, and interest of 488.72 M.
We use absolute and relative valuation methodologies to arrive at the intrinsic value of ADENTRA. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ADENTRA based exclusively on its fundamental and basic technical indicators. By analyzing ADENTRA's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of ADENTRA's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of ADENTRA. We calculate exposure to ADENTRA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ADENTRA's related companies.
ADENTRA financial ratios help investors to determine whether ADENTRA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ADENTRA with respect to the benefits of owning ADENTRA security.